Back
Tekla Healthcare Opportunities Fund Vs. VanEck Pharmaceutical ETF Industry Stock Comparison
Sell
48
THQ
Tekla Healthcare Opportunities Fund
Last Price:
21.96
Seasonality Move:
-1.03%
Sell
48
PPH
VanEck Pharmaceutical ETF
Last Price:
96.32
Seasonality Move:
1.21%
Sell
48
Tekla Healthcare Opportunities Fund (THQ)
is a Sell
Is Tekla Healthcare Opportunities Fund a Buy, Sell or Hold?
- The current Tekla Healthcare Opportunities Fund [THQ] share price is $22.06. The Score for THQ is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- THQ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
VanEck Pharmaceutical ETF (PPH)
is a Sell
Is VanEck Pharmaceutical ETF a Buy, Sell or Hold?
- The current VanEck Pharmaceutical ETF [PPH] share price is $96.39. The Score for PPH is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- PPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
THQ Stock Price Chart
What is Tekla Healthcare Opportunities Fund's stock price today?
-
The Tekla Healthcare Opportunities Fund share price today is $22.06
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and THQ is experiencing buying pressure, which is a positive indicator for future bullish movement.
PPH Stock Price Chart
What is VanEck Pharmaceutical ETF's stock price today?
-
The VanEck Pharmaceutical ETF share price today is $96.39
The current trend is moderately bearish and PPH is experiencing slight selling pressure.
THQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 62.38 | Buy |
| Chaikin Money Flow: | 103686 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.46 - 21.88) | Buy |
| Bollinger Bands (100): | (20.13 - 21.55) | Buy |
PPH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.37 | Buy |
| Relative Strength Index (14 RSI): | 46.23 | Sell |
| Chaikin Money Flow: | -21198 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (96.79 - 98.45) | Sell |
| Bollinger Bands (100): | (89.92 - 96.2) | Buy |
THQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.87 | Buy |
| 20-day SMA: | 21.74 | Buy |
| 50-day SMA: | 21.47 | Buy |
| 200-day SMA: | 19.93 | Buy |
| 8-day EMA: | 21.89 | Buy |
| 20-day EMA: | 21.73 | Buy |
| 50-day EMA: | 21.4 | Buy |
| 200-day EMA: | 20.19 | Buy |
PPH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 97.27 | Sell |
| 20-day SMA: | 97.75 | Sell |
| 50-day SMA: | 95.44 | Buy |
| 200-day SMA: | 89.53 | Buy |
| 8-day EMA: | 97.17 | Sell |
| 20-day EMA: | 97.14 | Sell |
| 50-day EMA: | 95.7 | Buy |
| 200-day EMA: | 90.11 | Buy |
Tekla Healthcare Opportunities Fund Earnings Growth & THQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
VanEck Pharmaceutical ETF Earnings Growth & PPH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Tekla Healthcare Opportunities Fund Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
VanEck Pharmaceutical ETF Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||